Evidence map›Paper›PMID 18156288›Full record

ArticleEukaryotic cell2008

Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.

Aki Yoneda, Tamara L Doering

Abstract read
In one paragraph

Article in Eukaryotic cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Evolutionary uniqueeLife · 2025
    Article
  2. Phenotypic characterization ofMicrobiology spectrum · 2024
    Article
  3. Phenotypic characterization ofbioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Article
  6. Influence of Pathogen Carbon Metabolism on Interactions With Host Immunity.Frontiers in cellular and infection microbiology · 2022
    Review
  7. Article
  8. Fungicidal Activity of Recombinant Javanicin againstMolecules (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Article
  11. ExploringThe Journal of biological chemistry · 2020
    Article
  12. Article
  13. Review
  14. The capsule ofVirulence · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aki YonedaDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Tamara L Doering

Funding

GLYCAN BIOSYNTHESIS IN CRYPTOCOCCUS NEOFORMANSR01GM071007 · NIGMS · WASHINGTON UNIVERSITY · PI DOERING, TAMARA L · 2004 to 2010
$1.9M
Polysaccharide capsule export in the fungal pathogen Cryptococcus neoformansR21AI073380 · NIAID · WASHINGTON UNIVERSITY · PI DOERING, TAMARA L · 2007 to 2008
$408k
NIAID NIH HHS AI073380NIAID NIH HHS R21 AI073380NIGMS NIH HHS GM71007NIGMS NIH HHS R01 GM071007
6 · The paper itself

Abstract

The fungal pathogen Cryptococcus neoformans regulates its polysaccharide capsule depending on environmental stimuli. To investigate whether capsule polymers change under different growth conditions, we analyzed shed capsules at physiological concentrations without physical perturbation. Our results indicate that regulation of capsule size is mediated at the level of individual polysaccharide molecules.

Indexed as

Antibodies, MonoclonalCryptococcus neoformansPolysaccharidesAntibodies, MonoclonalglucuronoxylomannanPolysaccharides

Identifiers

PMID18156288
PMCPMC2268517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.